Difference between revisions of "Cisplatin"
Jump to navigation
Jump to search
| Line 2: | Line 2: | ||
Mechanism | Mechanism | ||
| + | *Platinum analog, alkylating-like | ||
| + | *metabolism | ||
| + | *excretion | ||
| + | *CYP450 | ||
Dosing | Dosing | ||
**Renal dose adjustments | **Renal dose adjustments | ||
**Hepatic dose adjustments | **Hepatic dose adjustments | ||
| + | |||
| + | Routes of administration | ||
Side effects | Side effects | ||
| Line 11: | Line 17: | ||
[http://hemonc.org/index.php?title=Special:WhatLinksHere/Cisplatin List of regimens containing cisplatin] | [http://hemonc.org/index.php?title=Special:WhatLinksHere/Cisplatin List of regimens containing cisplatin] | ||
| + | |||
| + | ==References== | ||
| + | [http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018057s080lbl.pdf Cisplatin package insert (8/2011)] | ||
Revision as of 04:41, 12 November 2011
Template to be used for chemotherapies:
Mechanism
- Platinum analog, alkylating-like
- metabolism
- excretion
- CYP450
Dosing
- Renal dose adjustments
- Hepatic dose adjustments
Routes of administration
Side effects
- informed consent info
List of regimens containing cisplatin